|Application ||WB, E|
|Calculated MW||59087 Da|
|Other Names||M-phase inducer phosphatase 1, Dual specificity phosphatase Cdc25A, CDC25A|
|Target/Specificity||This Cdc25A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human Cdc25A.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||Cdc25A Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Tyrosine protein phosphatase which functions as a dosage-dependent inducer of mitotic progression. Directly dephosphorylates CDK1 and stimulates its kinase activity. Also dephosphorylates CDK2 in complex with cyclin E, in vitro.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
CDC25A is a member of the CDC25 family of phosphatases. CDC25A is required for progression from G1 to the S phase of the cell cycle. It activates the cyclin-dependent kinase CDC2 by removing two phosphate groups. CDC25A is specifically degraded in response to DNA damage, which prevents cells with chromosomal abnormalities from progressing through cell division. CDC25A is an oncogene, although its exact role in oncogenesis has not been demonstrated.
Ito, Y., et al., Int. J. Mol. Med. 13(3):431-435 (2004).
Nemoto, K., et al., Prostate 58(1):95-102 (2004).
Goloudina, A., et al., Cell Cycle 2(5):473-478 (2003).
Chen, M.S., et al., Mol. Cell. Biol. 23(21):7488-7497 (2003).
Chow, J.P., et al., Mol. Biol. Cell 14(10):3989-4002 (2003).
If you have any additional inquiries please email technical services at email@example.com.